H Li1, J Sun2, J Du3, F Wang4, R Fang5, C Yu5, J Xiong5, W Chen5, Z Lu1, J Liu5. 1. Department of Emergency Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. 2. Department of Neurology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. 3. Department of Clinical Microbiology and Immunology, Wenzhou Medical University, Wenzhou, Zhejiang, China. 4. Departments of Pathophysiology, Wenzhou Medical University, Wenzhou, Zhejiang, China. 5. Department of Preventive Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Abstract
BACKGROUND: Traumatic brain injury (TBI) is a common occurrence following gastrointestinal dysfunction. Recently, more and more attentions are being focused on gut microbiota in brain and behavior. Glucagon-like peptide-1 (GLP-1) is considered as a mediator that links the gut-brain axis. The aim of this study was to explore the neuroprotective effects of Clostridium butyricum (Cb) on brain damage in a mouse model of TBI. METHODS: Male C57BL/6 mice were subjected to a model of TBI-induced by weight-drop impact head injury and were treated intragastrically with Cb. The cognitive deficits, brain water content, neuronal death, and blood-brain barrier (BBB) permeability were evaluated. The expression of tight junction (TJ) proteins, Bcl-2, Bax, GLP-1 receptor (GLP-1R), and phosphorylation of Akt (p-Akt) in the brain were also measured. Moreover, the intestinal barrier permeability, the expression of TJ protein and GLP-1, and IL-6 level in the intestine were detected. RESULTS: Cb treatment significantly improved neurological dysfunction, brain edema, neurodegeneration, and BBB impairment. Meanwhile, Cb treatment also significantly increased the expression of TJ proteins (occludin and zonula occluden-1), p-Akt and Bcl-2, but decreased expression of Bax. Moreover, Cb treatment exhibited more prominent effects on decreasing the levels of plasma d-lactate and colonic IL-6, upregulating expression of Occludin, and protecting intestinal barrier integrity. Furthermore, Cb-treated mice showed increased the secretion of intestinal GLP-1 and upregulated expression of cerebral GLP-1R. CONCLUSIONS: Our findings demonstrated the neuroprotective effect of Cb in TBI mice and the involved mechanisms were partially attributed to the elevating GLP-1 secretion through the gut-brain axis.
BACKGROUND:Traumatic brain injury (TBI) is a common occurrence following gastrointestinal dysfunction. Recently, more and more attentions are being focused on gut microbiota in brain and behavior. Glucagon-like peptide-1 (GLP-1) is considered as a mediator that links the gut-brain axis. The aim of this study was to explore the neuroprotective effects of Clostridium butyricum (Cb) on brain damage in a mouse model of TBI. METHODS: Male C57BL/6 mice were subjected to a model of TBI-induced by weight-drop impact head injury and were treated intragastrically with Cb. The cognitive deficits, brain water content, neuronal death, and blood-brain barrier (BBB) permeability were evaluated. The expression of tight junction (TJ) proteins, Bcl-2, Bax, GLP-1 receptor (GLP-1R), and phosphorylation of Akt (p-Akt) in the brain were also measured. Moreover, the intestinal barrier permeability, the expression of TJ protein and GLP-1, and IL-6 level in the intestine were detected. RESULTS:Cb treatment significantly improved neurological dysfunction, brain edema, neurodegeneration, and BBB impairment. Meanwhile, Cb treatment also significantly increased the expression of TJ proteins (occludin and zonula occluden-1), p-Akt and Bcl-2, but decreased expression of Bax. Moreover, Cb treatment exhibited more prominent effects on decreasing the levels of plasma d-lactate and colonic IL-6, upregulating expression of Occludin, and protecting intestinal barrier integrity. Furthermore, Cb-treated mice showed increased the secretion of intestinal GLP-1 and upregulated expression of cerebral GLP-1R. CONCLUSIONS: Our findings demonstrated the neuroprotective effect of Cb in TBI mice and the involved mechanisms were partially attributed to the elevating GLP-1 secretion through the gut-brain axis.
Authors: Laura M Cox; Hadi Abou-El-Hassan; Amir Hadi Maghzi; Julia Vincentini; Howard L Weiner Journal: Brain Res Date: 2019-08-13 Impact factor: 3.252
Authors: A Clark; R Zelmanovich; M R Hosseini Siyanaki; M Michel; C Hanna; C Davidson; B Lucke-Wold Journal: Neurol Neurother Open Access J Date: 2022-08-16
Authors: Lucille M Yanckello; Brian Fanelli; Scott McCulloch; Xin Xing; McKenna Sun; Tyler C Hammond; Rita Colwell; Zezong Gu; Aaron C Ericsson; Ya-Hsuan Chang; Adam D Bachstetter; Ai-Ling Lin Journal: J Cell Immunol Date: 2022
Authors: Jonathan Willman; Matthew Willman; Ramya Reddy; Anna Fusco; Sai Sriram; Yusuf Mehkri; Jude Charles; Joel Goeckeritz; Brandon Lucke-Wold Journal: Clin Transl Discov Date: 2022-10-10